BioSpace News Archive

Axiom Real-Time Metrics (“Axiom”), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at DIA 2022 June 20-22 in Chicago, Il.

The global heparin market size is expected to reach USD 7.55 Billion in 2028 at a CAGR of 1.4% during the forecast period, according to the latest report by Reports and Data.

The global T-cell therapy market size is expected to reach USD 21 Billion in 2028 and register a CAGR of 20.4% over the forecast period, according to the latest report by Reports and Data.

BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) will host the first edition of the Company’s Innovation Series on Wednesday, June 29th, 2022.

Human Longevity, Inc., built by the pioneers of the human genome sequencing effort, and Freedom Acquisition I Corporation, a publicly traded special purpose acquisition company, announced that they have signed a non-binding letter of intent for a proposed business combination that would result in HLI becoming a publicly listed company.

Apotex Inc., Canada’s leading pharmaceutical manufacturer of generic medicines, announced today the launch of APO-ApixabanTM tablets, Canada’s first generic alternative to Eliquis®.

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a conference call Tuesday, June 21st at 8:00 a.m. E.T. to review topline results from Study 041 of Translarna™ (ataluren) in patients with nonsense mutation Duchenne muscular dystrophy.

Medicure Inc. is pleased to announce that the following individuals were elected as directors at its Annual General Meeting of shareholders held on June 16, 2022: Dr. Albert Friesen, Gerald McDole, Brent Fawkes, Dr. Arnold Naimark, Peter Quick and James Kinley.

Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new vaccines and therapies, announced the completion of a US$42 million Series A financing round.

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite Center) at Singapore’s Duke-NUS Medical School, jointly established by Duke University and the National University of Singapore (NUS) as a graduate-entry medical school and research powerhouse.